Home › Research › Tau biomarkers
Associations of plasma SMOC1 and soluble IL6RA levels with the progression from mild cognitive impairment to dementia
Morató X, Puerta R, Cano A, Orellana A, de Rojas I, Capdevila M, Montrreal L, Rosende-Roca M et al.. Brain, behavior, & immunity - health, 2024-11-16
Topic: Brain proteins, microglia and lab models
Plain-language summary
Despite the central role attributed to neuroinflammation in the etiology and pathobiology of Alzheimer's disease (AD), the direct link between levels of inflammatory mediators in blood and cerebrospinal fluid (CSF) compartments, as well as their potential implications for AD diagnosis and progression, remains inconclusive. Moreover, there is debate on whether inflammation has a protective or detrimental effect on disease onset and progression. Indeed, distinct immunological mechanisms may govern protective and damaging effects at early and late stages, respectively.
What this study adds
Evidence grade: Low
The record lists 485 participants. This study aimed to identify inflammatory mediators in blood and spinal fluid that correlate between the body and the central nervous system and to assess their potential significance for Alzheimer's diagnosis and progression. It is an observational study and does not test any treatment or cure.
Taken from this record’s own fields, not from reading the paper. The grade is assigned from the abstract’s wording; what that means.
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
APA 7th
Morató, X., Puerta, R., Cano, A., Orellana, A., de Rojas, I., Capdevila, M., et al. (2024). Associations of plasma SMOC1 and soluble IL6RA levels with the progression from mild cognitive impairment to dementia. Brain, behavior, & immunity - health. https://doi.org/10.1016/j.bbih.2024.100899
Vancouver
Morató X, Puerta R, Cano A, Orellana A, de Rojas I, Capdevila M, et al. Associations of plasma SMOC1 and soluble IL6RA levels with the progression from mild cognitive impairment to dementia. Brain, behavior, & immunity - health. 2024. doi:10.1016/j.bbih.2024.100899. PMID: 39640195.
BibTeX
@article{morato2024-39640195,
author = {Morató, X. and Puerta, R. and Cano, A. and Orellana, A. and de Rojas, I. and Capdevila, M. and Montrreal, L. and Rosende-Roca, M. and others},
title = {{Associations of plasma SMOC1 and soluble IL6RA levels with the progression from mild cognitive impairment to dementia}},
journal = {Brain, behavior, \& immunity - health},
year = {2024},
doi = {10.1016/j.bbih.2024.100899},
pmid = {39640195},
url = {https://doi.org/10.1016/j.bbih.2024.100899}
}
Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. The record's author list ends in “et al.”, so not every author is named. Check the citation against the original before you use it.
Key findings
- Moreover, there is debate on whether inflammation has a protective or detrimental effect on disease onset and progression.
- Indeed, distinct immunological mechanisms may govern protective and damaging effects at early and late stages, respectively.
- This study aims to (i) identify inflammatory mediators demonstrating robust correlations between peripheral and central nervous system (CNS) compartments by means of plasma and CSF analysis, respectively, and (ii) assess their potential significance in the context of AD and disease progression from mild cognitive impairment (MCI) to dementia.
- To achieve this, we have examined the inflammatory profile of a well-defined subcohort comprising 485 individuals from the Ace Alzheimer Center Barcelona (ACE).
Why it matters
This study aimed to identify inflammatory mediators in blood and spinal fluid that correlate between the body and the central nervous system and to assess their potential significance for Alzheimer's diagnosis and progression. It is an observational study and does not test any treatment or cure.
New to this subject? Start with our plain-English guide: Blood tests & biomarkers →
Study details
- Participants485
- Evidence strengthLow
How this study scored 44/100
Published in a peer-reviewed journal. Scored zero for study design, effect reported and randomized / blinded because the record does not state it.
| Component | Points | Why |
|---|---|---|
| Journal tier | 7 / 10 | Tier 3 — peer-reviewed journal (Brain, behavior, & immunity - health) |
| Journal's citation record | 0 / 4 | Brain Behavior & Immunity - Health: journal h-index 53 (OpenAlex, 2026-10-29) |
| Study design | 0 / 12 | No study design recorded — scores zero, not guessed (not stated in the record — scored 0) |
| Strength of evidence | 1 / 5 | Rated “low” in our summary |
| Peer-review validation | 10 / 10 | Peer-reviewed. Published as an article in a named peer-reviewed journal. |
| How recent | 4 / 5 | 2024 — within 3 year(s) of the newest study here |
| Sample size | 2 / 4 | 485 participants |
| Effect reported | 0 / 3 | No effect size reported — scores zero (not stated in the record — scored 0) |
| Studied in people | 3 / 3 | Studied in people (participant count stated) |
| Randomized / blinded | 0 / 2 | No randomization or blinding stated — scores zero (not stated in the record — scored 0) |
| Times cited | 2 / 7 | Cited 9 times (OpenAlex, 2026-10-10) |
| Citations per year | 1 / 5 | 2.2 citations a year over 4 year(s) since 2024 |
| Impact for its field and year | 2 / 6 | Cited 2.4× the average for papers of its field and year (OpenAlex FWCI) |
| Cited by studies here | 1 / 6 | Cited by 1 other studies in this library |
| Still being cited | 1 / 4 | Cited 9 times in 2024–2026 (2026 still in progress; OpenAlex) |
| Senior author's track record | 3 / 4 | Last-listed author Agustı́n Ruiz: h-index 67 (OpenAlex, whole career) |
| Institution's track record | 1 / 3 | Universitat de Barcelona: institution h-index 1,049 (OpenAlex) |
| Multicenter collaboration | 2 / 3 | OpenAlex lists 8 institution(s) in 2 countries |
| Indexed in PubMed | 2 / 2 | Indexed in PubMed (PMID 39640195) |
| Free to read | 2 / 2 | Free to read |
| Total | 44 / 100 | — |
What each of these 20 components measures, and what this score is not →
Read the original
- DOI: 10.1016/j.bbih.2024.100899
- PubMed: 39640195
- Original source →
- Free full text: Brain Behavior & Immunity - Health →
Full text: free to read — OpenAlex lists this copy as free to read: the link above (checked 6 Feb 1020).
Related
Studies in the library that share something with this one. The line above each title says what.
Studies this one cites
Referenced by this study and also in the alzhub library, so you can read them here.
Later studies that cite this one
1 study in the alzhub library lists this one in its references.
Related studies in Tau biomarkers from nearby years
Also tagged “cerebrospinal”
820 studies in the library carry the topic tag “cerebrospinal”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 820 tagged studies.